Novo Nordisk Stock Pops On 'Significant' Weight Loss For Oral Wegovy

Novo Nordisk (NVO) stock surged Thursday after its oral version of Wegovy helped patients lose a "significant" amount of weight over the course of 64 weeks. Patients lost on average of 16.6% of their body weight while taking oral semaglutide, the act... [4416 chars]